Soon after Sarah’s 12 week scan she was diagnosed with Hodgkin’s Lymphoma. Sarah shares her story of battling cancer and the hope she had.
Social media licence
Ministry use licence
A few days after Sarah's 12 week scan she was diagnosed with Hodgkin's Lymphoma.
In this short video, Sarah shares the concern she felt about being pregnant and having to deal with chemotherapy. When most newly expectant mothers are limiting their diets to avoid potentially harmful bacteria entering their systems, she had to ingest powerful drugs with no real idea what the impact might be for the baby growing inside. Despite it being a confusing, tough time, she also shares how this struggle has actually led them, as a family, to rely on God all the more. Sarah explains how this experience of suffering and difficulty has caused them to look forward with renewed confidence to an amazing eternal future where there will be no crying, no sickness and no cancer.
Possible Discussion Questions
Go Chatter has created a number of evangelistic videos linked to current events or trending topics, videos with a seasonal emphasis and others that feature someone’s life-story.
Permission has been granted by the content-creator to upload this video unedited directly to your personal or church’s social media. The social media license is an additional license that some videos have as some content creators have allowed some of their videos to be uploaded by churches to their social media channels.
By purchasing this video, you are purchasing a license to use and show this video as part of your ministry in ONE church.
You are granted permission to use the video in:
1) Offline services, school assemblies or lessons, groups or at events (including youth, kids and midweek groups and events)
2) Online services or assemblies that are streamed or pre-recorded. (For online services, the content video you have purchased should be part of a complete church service which must be at least 20 minutes long.)
3) Online small groups meeting over Zoom or a similar video call platforms.